New advances in amblyopia therapy I: binocular therapies and pharmacologic augmentation.

ABSTRACT: Amblyopia therapy options have traditionally been limited to penalisation of the non-amblyopic eye with either patching or pharmaceutical penalisation. Solid evidence, mostly from the Pediatric Eye Disease Investigator Group, has validated both number of hours a day of patching and days per week of atropine use. The use of glasses alone has also been established as a good first-line therapy for both anisometropic and strabismic amblyopia. Unfortunately, visual acuity equalisation or even improvement is not always attainable with these methods. Additionally, non-compliance with prescribed therapies contributes to treatment failures, with data supporting difficulty adhering to full treatment sessions. Interest in alternative therapies for amblyopia treatment has long been a topic of interest

SUBMITTER: Kraus CL 

PROVIDER: S-EPMC6241622 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature